Please do not adjust margins
Organic & Biomolecular Chemistry
Page 5 of 6
COMMUNICATION
Journal Name
C15H11N3+H+ 234.1026, found 234.1027.DOI: 10.1039/C6OB01827K
7-Methyl-2-phenyl-2H-indazole (2e): Synthesized via GP2;
colorless oil (33.3 mg, 80% isolated yield); Rf: 0.51 (PE:
EA=10:1); 1H NMR (400 MHz, CDCl3): δ 8.38 (s, 1H), 7.95 – 7.90
(m, 2H), 7.58 – 7.50 (m, 3H), 7.44 – 7.37 (m, 1H), 7.12 – 7.07
(m, 1H), 7.04 (dd, J = 8.2, 6.7 Hz, 1H), 2.71 (s, 3H); 13C NMR (100
MHz, CDCl3): δ 150.3, 140.8, 129.7, 128.2, 127.9, 125.8, 122.9,
122.7, 121.3, 120.9, 117.9, 17.3; GC-MS: 208; HRMS (ESI
positive mode) calcd for C14H12N2+H+ 209.2659, found
209.2661.
Methyl 5-methyl-2-phenyl-2H-indazole-7-carboxylate (2f):
Synthesized via modified GP2 (24 h); white crystal (21.3 mg,
40% isolated yield); Rf: 0.51 (PE: EA=4:1); M.p. 109-111 oC; 1H
NMR (400 MHz, CDCl3): δ 8.41 (s, 1H), 7.99 (d, J = 1.6 Hz, 1H),
7.97 – 7.93 (m, 2H), 7.69 – 7.66 (m, 1H), 7.54 – 7.47 (m, 2H),
7.42 – 7.36 (m, 1H), 4.04 (s, 3H), 2.46 (d, J = 0.8 Hz, 3H); 13C
NMR (100 MHz, CDCl3): δ 166.8, 146.0, 140.5, 134.6, 131.1,
129.6, 128.2, 124.9, 124.6, 121.2, 120.5, 119.4, 52.4, 21.5; GC-
MS: 266; HRMS (ESI positive mode) calcd for C16H14N2O2+H+
267.1128, found 267.1129.
Experimental Section
General procedure for azobenzene synthesis (GP1)16
2.2 mmol of aniline was added into a solution of nitroso-
benzene (2.0 mmol) in 20 mL acetic acid. The reaction mixture
o
was stirred at 30 C in darkness for 2 days. After the reaction
completion, the mixture was diluted with 20 mL water and
extracted 3 time with 20 mL petroleum ether (PE). The organic
phase was combined, washed with NaHCO3 solution, dried and
evaporated. The obtained residual was eluted over silica gel
column with PE-dichloromathane (DCM) to give the
corresponding azobenzenes. The characterization data for
azobenzenes are displayed in ESI.
General procedure for 2H-indazole synthesis (GP2)
A seal tube was charged with 0.2 mmol of azobenzene, 0.4
mmol of NaOAc (32.8 mg), 0.21 mmol of I2 (54 mg), 1 mL DCE
and then moved into an oil bath which was preheated to 120
oC. After 12 h, the reaction was cooled to room temperature
and quenched with 1 mL of saturated NaHCO3 solution and 3
drops of saturated Na2S2O3 solution. Then, the mixture was
extracted with ethyl acetate (EA) and the obtained organic
phase was dried and evaporated. The residual was eluted over
Silica gel column with PE-EA to give the corresponding 2H-
indazoles.
7-Bromo-5-methyl-2-phenyl-2H-indazole (2g) and 7-iodo-5-
methyl-2-phenyl-2H-indazole (2h): Synthesized using 1g via
modified GP2 (24 h); white crystal (42.7 mg, 70% isolated yield,
2g: 2h= 1:0.61); Rf: 0.41(PE: EA=10:1); HRMS (ESI positive
mode) calcd for C14H11N2Br+H+ 287.1078, found 287.1075;
HRMS (ESI positive mode) calcd for C14H11N2I+H+ 335.0040,
found 335.0039.
2-Mesityl-5,7-dimethyl-2H-indazole (2a): Synthesized via
GP2; white solid (44.9 mg, 85% isolated yield); Rf: 0.42 (PE:
7-Iodo-5-methyl-2-phenyl-2H-indazole (2h): Synthesized via
GP2; white solid (56.4 mg, 85% isolated yield); M.p. 108-110
oC; Rf: 0.41 (PE: EA=10:1); 1H NMR (400 MHz, CDCl3): δ 8.41 (d,
J = 6.7 Hz, 1H), 7.93 – 7.87 (m, 2H), 7.66 (s, 1H), 7.54 – 7.48 (m,
2H), 7.42 – 7.36 (m, 2H), 2.38 (s, 3H); 13C NMR (100 MHz, CDCl3):
δ 149.7, 140.4, 139.4, 133.4, 129.6, 128.2, 122.3, 121.2, 121.2,
119.0, 83.9, 21.4; GC-MS: 334; HRMS (ESI positive mode) calcd
for C14H11IN2+H+ 335.0040, found 335.0039.
o
1
EA=10:1); M.p. 114-116 C; H NMR (400 MHz, CDCl3): δ 7.83
(s, 1H), 7.34 (s, 1H), 6.98 (s, 2H), 6.97 (s, 1H), 2.65 (s, 3H), 2.43
(s, 3H), 2.36 (s, 3H), 1.97 (s, 6H); 13C NMR (100 MHz, CDCl3): δ
148.6, 139.2, 137.7, 135.5, 131.6, 128.9, 128.2, 127.9, 124.0,
122.0, 115.9, 21.9, 21.2, 17.4, 17.3; GC-MS: 264; HRMS (ESI
positive mode) calcd for C18H20N2+H+ 265.1699, found
265.1700.
5-Methyl-2,7-diphenyl-2H-indazole (2i): Synthesized via GP2;
colorless oil (29.0 mg, 51% isolated yield); Rf: 0.52 (PE:
EA=10:1); 1H NMR (400 MHz, CDCl3): δ 8.37 (s, 1H), 8.17 – 8.13
(m, 2H), 7.97 – 7.93 (m, 2H), 7.55 – 7.49 (m, 4H), 7.45 – 7.34
(m, 4H), 2.50 (s, 3H); 13C NMR (100 MHz, CDCl3): δ 147.2, 140.8,
138.3, 132.3, 130.6, 129.6, 129.0, 128.5, 128.4, 127.7, 127.6,
124.3, 120.9, 119.5, 117.9, 22.0; GC-MS: 284; HRMS (ESI
positive mode) calcd for C20H16N2+H+ 285.1386, found
285.1384.
5,7-Dimethyl-2-phenyl-2H-indazole (2b): Synthesized via
GP2; white solid (35.5 mg, 80% isolated yield); Rf: 0.51 (PE:
EA=10:1); M.p. 62-64 oC; 1H NMR (400 MHz, CDCl3): δ 8.25 (s,
1H), 7.91 (d, J = 7.5 Hz, 2H), 7.52 (t, J = 7.9 Hz, 2H), 7.38 (t, J =
7.4 Hz, 1H), 7.28 (s, 1H), 6.95 (s, 1H), 2.68 (s, 3H), 2.41 (s, 3H);
13C NMR (100 MHz, CDCl3): δ 149.3, 140.9, 132.2, 129.6, 128.9,
127.8, 127.6, 123.0, 121.1, 119.8, 115.8, 21.9, 17.2; GC-MS:
222; HRMS (ESI positive mode) calcd for C15H14N2+H+ 223.1230,
found 223.1232.
5,7-Dimethyl-2,3-diphenyl-2H-indazole (2j): Synthesized via
modified GP2 (1 h); colorless crystal (51.5 mg, 86% isolated
5-Methoxy-7-methyl-2-phenyl-2H-indazole (2c): Synthesized
via modified GP2 (4 h); white solid (40.4 mg, 85% isolated
o
1
yield); Rf: 0.44 (PE: EA=10:1); M.p. 120-122 C; H NMR (400
MHz, CDCl3): δ 7.50 – 7.44 (m, 2H), 7.42 – 7.30 (m, 9H), 7.01 (s,
1H), 2.70 (s, 3H), 2.42 (s, 3H); 13C NMR (100 MHz, CDCl3): δ
148.4, 140.5, 134.9, 132.4, 130.4, 129.8, 129.8, 129.1, 128.8,
128.2, 128.1, 127.6, 126.3, 121.9, 116.0, 22.0, 17.2; GC-MS:
298; HRMS (ESI positive mode) calcd for C21H18N2+H+ 299.1543,
found 299.1541.
o
1
yield); Rf: 0.36 (PE: EA=10:1); M.p. 100-101 C; H NMR (400
MHz, CDCl3): δ 8.24 (s, 1H), 7.91 – 7.86 (m, 2H), 7.54 – 7.48 (m,
2H), 7.39 – 7.34 (m, 1H), 6.82 – 6.79 (m, 1H), 6.74 (d, J = 2.2 Hz,
1H), 3.84 (s, 3H), 2.64 (s, 3H); 13C NMR (100 MHz, CDCl3): δ
155.8, 147.4, 140.9, 129.9, 129.6, 127.6, 122.6, 120.9, 120.8,
119.7, 93.8, 55.4, 17.1; GC-MS: 238; HRMS (ESI positive mode)
calcd for C15H14N2O+H+ 239.1178, found 239.1179.
Ethyl 5,7-dimethyl-2-phenyl-2H-indazole-3-carboxylate (2k):
Synthesized via modified GP2 (1 h); colorless crystal (42.4 mg,
72% isolated yield); Rf: 0.34 (PE: EA=10:1); M.p. 122-124 oC; 1H
NMR (400 MHz, CDCl3): δ 7.69 (s, 1H), 7.51 (s, 5H), 7.02 (s, 1H),
4.34 (q, J = 7.1 Hz, 2H), 2.65 (s, 3H), 2.48 (s, 3H), 1.32 (t, J = 7.1
Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 159.9, 147.9, 141.4,
135.9, 129.3, 129.2, 128.7, 128.5, 126.6, 124.6, 124.5, 117.2,
7-Methyl-2-phenyl-2H-indazole-5-carbonitrile
(2d):
Synthesized via modified GP2 (24 h); white crystal (36.3 mg,
78% isolated yield); Rf: 0.15 (PE: EA=10:1); M.p. 181-183 oC; 1H
NMR (400 MHz, CDCl3): δ 8.51 (s, 1H), 8.01 (s, 1H), 7.91 (d, J =
7.7 Hz, 2H), 7.56 (t, J = 7.9 Hz, 2H), 7.45 (t, J = 7.4 Hz, 1H), 7.18
(s, 1H), 2.68 (s, 3H); 13C NMR (100 MHz, CDCl3): δ 150.2, 140.1,
130.3, 129.9, 128.8, 126.1, 125.8, 122.6, 121.5, 121.4, 120.1,
This journal is © The Royal Society of Chemistry 20xx
J. Name., 2013, 00, 1-3 | 5
Please do not adjust margins